TLDR:
- 13books Capital raises £121m for fintech venture capital fund, with British Patient Capital pledging £25m
- The fund will focus on investing in early-stage fintech companies across Europe, with ticket sizes ranging from £1m to £7m
UK-based fintech investor 13books Capital has successfully raised £121m for a venture capital fund that will be used to invest in fintech companies across Europe. The fund will primarily focus on Seed to Series A stages, with ticket sizes ranging from £1m to £7m. British Patient Capital, the venture capital arm of the UK government-owned British Business Bank, has pledged £25m to the fund.
Steve Gibson, partner at 13books Capital, expressed that there is a growing desire among European fintech entrepreneurs for a sector-focused, founder-led venture platform with impactful networks across the industry. The fund has already made 19 investments in fintech companies, including UK startup Lune, and has seen success with investments in Nasdaq-listed Roadzen and Ncino.
Christine Hockley, managing director of funds at BPC, highlighted the importance of investing in innovative fintech businesses that will provide the necessary technology for the financial services sector. BPC manages over £3bn of assets and is committed to supporting high growth businesses in accessing the long-term financing needed to scale up.
In conclusion, the successful fundraising efforts of 13books Capital for their fintech venture capital fund, along with the support from British Patient Capital, demonstrate a strong commitment to investing in and supporting the next generation of pioneering fintech entrepreneurs in Europe.
